Original paper Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting

Author:

Adamczyk Agnieszka,Niemiec Joanna,Janecka Anna,Harazin-Lechowska Agnieszka,Ambicka Aleksandra,Grela-Wojewoda Aleksandra,Domagała-Haduch Małgorzata,Cedrych Ida,Majchrzyk Kaja,Kruczak Anna,Ryś Janusz,Jakubowicz Jerzy

Publisher

Termedia Sp. z.o.o.

Subject

General Medicine,Pathology and Forensic Medicine

Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer;Biologics: Targets and Therapy;2023-09

2. PTEN mutations prevalence in HER2-positive breast cancer patients;Revista de Senología y Patología Mamaria;2023-01

3. Advances in the Role of Androgen Receptors in Breast Cancer;Advances in Clinical Medicine;2023

4. Current State of Breast Cancer Diagnosis, Treatment, and Theranostics;Pharmaceutics;2021-05-14

5. Precision medicine for female-specific cancers: Strategies, challenges, and solutions;A Theranostic and Precision Medicine Approach for Female-Specific Cancers;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3